Work

P-230 Biomarkers associated with survival benefit to atezolizumab and bevacizumab for treatment of metastatic anal cancer

Year: 2023

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.04.286

Authors: V. Morris, H. Zhu, X. Li, B. Johnson, S. Prasad, A. Mahvash, B. Sun, S. Gite, R. Panduregan, E. Parra, M. Knafl, S. Woodman, C. Eng, D. Halperin

Institutions: The University of Texas MD Anderson Cancer Center, Vanderbilt University Medical Center

Language: English

Topic: Colorectal and Anal Carcinomas

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4382807283

Cites:

Cited by: 1

Related to: 10